We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Xermelo (telotristat ethyl) dosage for carcinoid syndrome diarrhea. Understand its strength, how to take it, what to do if you miss a dose, and when to consult your doctor.

Xermelo, with the active ingredient telotristat ethyl, is a medication prescribed for adults diagnosed with carcinoid syndrome who experience diarrhea that has not adequately responded to previous treatments. Carcinoid syndrome is a rare condition that can occur when a carcinoid tumor, typically found in the digestive tract or lungs, releases hormones that affect the body. One of the common symptoms of carcinoid syndrome is diarrhea, which can be persistent and disruptive to daily life. Xermelo works by targeting the production of serotonin in the body. Serotonin, a neurotransmitter, plays a role in various bodily functions, including digestion. In carcinoid syndrome, the tumor can cause an overproduction of serotonin, leading to symptoms like diarrhea. Xermelo inhibits an enzyme called tryptophan hydroxylase, which is involved in the production of serotonin. By reducing serotonin levels, Xermelo aims to alleviate the diarrhea associated with carcinoid syndrome.
Xermelo is available in a single strength: 250 milligrams (mg). It is formulated as a tablet that is meant to be swallowed whole. It is crucial not to crush, cut, or chew the Xermelo tablets, as this can affect how the medication is absorbed and its effectiveness. If you have difficulty swallowing tablets, it is advisable to consult your doctor or pharmacist for alternative suggestions or strategies.
The usual dosage of Xermelo for treating diarrhea in adults with carcinoid syndrome is one 250 mg tablet taken orally three times per day. It is important to take Xermelo with food to aid absorption. To maintain consistent levels of the medication in your body, it is recommended to spread the doses evenly throughout the day, ideally with meals such as breakfast, lunch, and dinner. Maintaining a regular schedule each day is also beneficial for optimal therapeutic effect.
In some instances, your doctor might prescribe a short-acting somatostatin analog injection, such as Sandostatin (octreotide acetate), in conjunction with Xermelo. If this is the case, your doctor will provide specific instructions on how to administer these medications. Generally, if you are taking both Xermelo and a somatostatin analog injection, you will be advised to inject the somatostatin analog at least 30 minutes after taking your Xermelo tablet. Always follow your doctor's precise instructions regarding the timing and administration of all prescribed medications.
Missing a dose of Xermelo can happen. If you realize you have missed a dose, the recommended course of action is to skip the missed dose entirely and proceed with your next scheduled dose at the usual time. It is important not to double up on doses or take an extra tablet to compensate for the missed one, as this could lead to an overdose and potentially harmful effects. To help prevent missing doses, consider using a medication reminder system, such as a reminder app on your smartphone or a daily pill organizer.
Taking more Xermelo than prescribed by your doctor can lead to serious health consequences. If you suspect you have taken too much Xermelo, it is crucial to seek medical attention immediately. You can contact your doctor right away for guidance. Additionally, you can reach out to a poison control center by calling 800-222-1222 or utilize their online resources. However, if you are experiencing severe symptoms, do not delay; call 911 (or your local emergency number) immediately or go to the nearest emergency room.
Xermelo is typically prescribed as a long-term treatment. If you and your healthcare provider determine that Xermelo is a safe and effective option for managing your carcinoid syndrome diarrhea, you will likely continue taking it for an extended period. The decision to continue treatment will be based on your individual response to the medication and its ongoing benefits in controlling your symptoms.
Information regarding the proper storage and disposal of Xermelo should be discussed with your doctor or pharmacist. They can provide guidance on how to keep the medication safe and effective, and how to dispose of any unused or expired medication according to health and safety regulations.
It is essential to maintain open communication with your doctor regarding your treatment with Xermelo. You should consult your doctor if:
Your doctor is your primary resource for managing your health condition and ensuring the safe and effective use of Xermelo.
This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026